Don't want ads? Subscribe or login now.

Pharma Co. Says Ex-CEO's Bias Allegations Come Up Short

By Caroline Simson · January 9, 2025, 7:48 PM EST

Canadian biopharmaceutical company FSD Pharma Inc. is urging the Third Circuit to affirm the enforcement of a $2 million arbitral award against its ex-CEO, arguing Wednesday that the former executive's allegations...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

FSD Pharma Inc v. Raza Bokhari

Case Number

24-2282

Court

Appellate - 3rd Circuit

Nature of Suit

3896 Arbitration

Date Filed

July 18, 2024

Recent Articles By Caroline

October 07, 2025
NY Appeals Court Nixes Chris Cuomo's Arbitrator Bias Claim
July 18, 2025
4th Circ. Remands Insurance Award Feud Over FAA Confusion
July 08, 2025
Americor Need Not Respond To Arbitral Order; Texas Judge
February 24, 2025
Justices Nix Whistleblower Suit Over Arbitral Vacatur Limits
February 06, 2025
Credit Union's Arb. Pact Not Unconscionable, Court Says
November 27, 2024
Ex-Disney Cruise Line Employee's Claim Sent To London
November 04, 2024
Justices Nix Ex-Adviser's Manifest Disregard Challenge
October 31, 2024
Ex-Citadel Reps Can't Escape Trade Secrets Suit
October 10, 2024
Ousted Chair's Claims To Go Before Arbitrator, Judge Says
October 03, 2024
Masseuse's Claim Must Be Arbitrated, Cruise Line Says